These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9460716)
1. Proliferation and DNA fragmentation in meningioma subtypes. Maier H; Wanschitz J; Sedivy R; Rössler K; Ofner D; Budka H Neuropathol Appl Neurobiol; 1997 Dec; 23(6):496-506. PubMed ID: 9460716 [TBL] [Abstract][Full Text] [Related]
2. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry. Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Karamitopoulou E; Perentes E; Tolnay M; Probst A Hum Pathol; 1998 Feb; 29(2):140-5. PubMed ID: 9490273 [TBL] [Abstract][Full Text] [Related]
4. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658 [TBL] [Abstract][Full Text] [Related]
5. Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas. Yang SY; Xu GM J Clin Neurosci; 2001 May; 8 Suppl 1():49-53. PubMed ID: 11386826 [TBL] [Abstract][Full Text] [Related]
6. Malignant meningioma: a clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry. Prayson RA Am J Clin Pathol; 1996 Jun; 105(6):719-26. PubMed ID: 8659446 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of proliferation index and expression of the RNA component of human telomerase (hTR) in papillary meningiomas. Rushing EJ; Colvin SM; Gazdar A; Miura N; White CL; Coimbra C; Burns DK J Neurooncol; 1999; 45(3):199-207. PubMed ID: 10845390 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labelling and immunohistochemical study. Ng HK; Chen L Histopathology; 1998 Jul; 33(1):64-70. PubMed ID: 9726051 [TBL] [Abstract][Full Text] [Related]
9. Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification. Uzüm N; Ataoğlu GA Tumori; 2008; 94(3):389-97. PubMed ID: 18705408 [TBL] [Abstract][Full Text] [Related]
10. Involvement of disregulated c-myc but not c-sis/PDGF in atypical and anaplastic meningiomas. Nagashima G; Aoyagi M; Yamamoto S; Wakimoto H; Tamaki M; Yamamoto K; Fujimoto T; Hirakawa K Clin Neurol Neurosurg; 2001 Apr; 103(1):13-8. PubMed ID: 11311470 [TBL] [Abstract][Full Text] [Related]
11. Expression of apoptotic and proliferation markers in meningiomas. Konstantinidou AE; Pavlopoulos PM; Patsouris E; Kaklamanis L; Davaris P J Pathol; 1998 Nov; 186(3):325-30. PubMed ID: 10211124 [TBL] [Abstract][Full Text] [Related]
12. Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome. Abramovich CM; Prayson RA Am J Clin Pathol; 2000 Jul; 114(1):84-92. PubMed ID: 10884803 [TBL] [Abstract][Full Text] [Related]
13. Comparative proteomic profiles of meningioma subtypes. Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085 [TBL] [Abstract][Full Text] [Related]
14. Expression of BCL-2 oncoprotein on tumor cells and tumor-infiltrating lymphocytes (TIL) in meningiomas. Roessler K; Dietrich W; Kitz K Neurosurg Rev; 1999 Dec; 22(4):205-9. PubMed ID: 10682928 [TBL] [Abstract][Full Text] [Related]
15. Topoisomerase II alpha as a reliable proliferation marker in meningiomas. Roessler K; Gatterbauer B; Kitz K Neurol Res; 2002 Apr; 24(3):241-3. PubMed ID: 11958416 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227 [TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231 [TBL] [Abstract][Full Text] [Related]
18. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Lamszus K; Lengler U; Schmidt NO; Stavrou D; Ergün S; Westphal M Neurosurgery; 2000 Apr; 46(4):938-47; discussion 947-8. PubMed ID: 10764269 [TBL] [Abstract][Full Text] [Related]
20. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases. Korshunov A; Shishkina L; Golanov A Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]